"Lung Adenocarcinoma - Pipeline Review, H2 2012" Now Available at Fast Market Research
Global Markets Direct's, 'Lung Adenocarcinoma - Pipeline Review, H2 2012', provides an overview of the Lung Adenocarcinoma therapeutic pipeline. This report provides information on the therapeutic development for Lung Adenocarcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Adenocarcinoma. 'Lung Adenocarcinoma - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release